Management of radioiodine ablation therapy in haemodialysis patients with thyroid cancer: a case series of two patients

Abstract Background Radioiodine (131I) therapy in treatment of thyroid cancer, has a biological clearance that is significantly reduced in end-stage kidney disease (ESKD), leading to increased radiation exposure and potential myelotoxicity. For ESKD patients on haemodialysis (HD), there is no standa...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Raymond Lin, Alessandra L. Malaroda, William J. Ryder, Veronica C. K. Wong, Nikki L. Wong
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-07-01
Colecção:	BMC Nephrology
Assuntos:	Haemodialysis Radioiodine therapy Thyroid cancer Nuclear medicine Case series
Acesso em linha:	https://doi.org/10.1186/s12882-025-04348-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!